Inhibition of amyloid fibrillogenesis and toxicity by a peptide chaperone (Q45232847)

11 December 2017

Inhibition of amyloid fibrillogenesis and toxicity by a peptide chaperone (English)

1 reference

11 December 2017

0 references

Puttur Santhoshkumar

1

1 reference

PubMed ID

15663196

11 December 2017

Krishna K Sharma

series ordinal

2

1 reference

11 December 2017

1 December 2004

1 reference

Molecular and Cellular Biochemistry

11 December 2017

1 reference

11 December 2017

267

1 reference

11 December 2017

1-2

1 reference

11 December 2017

147-155

1 reference

https://scigraph.springernature.com/pub.10.1023/b:mcbi.0000049373.15558.b8

11 December 2017

0 references

cites work

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates

1 reference

12 December 2020

Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease

1 reference

12 December 2020

Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease

1 reference

12 December 2020

Inhibition of Alzheimer beta-fibrillogenesis by melatonin

1 reference

12 December 2020

Molecular biology of the amyloid of Alzheimer's disease. An overview

1 reference

12 December 2020

beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria.

1 reference

12 December 2020

Toxicity of protein aggregates in PC12 cells: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.

1 reference

12 December 2020

Involvement of Oxidative Stress on the Impairment of Energy Metabolism Induced by Aβ Peptides on PC12 Cells: Protection by Antioxidants

1 reference

12 December 2020

Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease

1 reference

12 December 2020

Expression of alpha B-crystallin in Alzheimer's disease.

1 reference

12 December 2020

The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity.

1 reference

12 December 2020

Nerve growth factor potentiates the neurotoxicity of beta amyloid

1 reference

12 December 2020

Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease.

1 reference

12 December 2020

Aggregation of an amyloidogenic fragment of human islet amyloid polypeptide

1 reference

12 December 2020

Interaction of intracellular beta amyloid peptide with chaperone proteins

1 reference

12 December 2020

Selective inhibition of Abeta fibril formation

1 reference

12 December 2020

[18] Quantification of β-sheet amyloid fibril structures with thioflavin T

1 reference

12 December 2020

Interaction of alpha-lactalbumin with mini-alphaA-crystallin

1 reference

12 December 2020

The molecular chaperone, alpha-crystallin, inhibits amyloid formation by apolipoprotein C-II.

1 reference

12 December 2020

Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation

1 reference

12 December 2020

Hydrogen peroxide mediates amyloid beta protein toxicity

1 reference

12 December 2020

Chaperone-like activity of a synthetic peptide toward oxidized gamma-crystallin

1 reference

12 December 2020

Amyloid beta protein and the basis for Alzheimer's disease

1 reference

12 December 2020

Intracellular generation of amyloid beta-protein from amyloid beta-protein precursor fragment by direct cleavage with beta- and gamma-secretase.

1 reference

12 December 2020

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

1 reference

12 December 2020

Cleavage of amyloid beta peptide during constitutive processing of its precursor

1 reference

12 December 2020

Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease

1 reference

12 December 2020

Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.

1 reference

12 December 2020

Inhibition of amyloid beta-protein production in neural cells by the serine protease inhibitor AEBSF.

1 reference

12 December 2020

Interaction between beta-amyloid and lens alphaB-crystallin.

1 reference

12 December 2020

Structural and kinetic features of amyloid beta-protein fibrillogenesis

1 reference

12 December 2020

Arrest of beta-amyloid fibril formation by a pentapeptide ligand

1 reference

12 December 2020

Inhibitors of fibril formation and cytotoxicity of beta-amyloid peptide composed of KLVFF recognition element and flexible hydrophilic disrupting element.

1 reference

12 December 2020

A strategy for designing inhibitors of beta-amyloid toxicity

1 reference

12 December 2020

Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease.

1 reference

12 December 2020

Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease.

1 reference

12 December 2020

Laminin inhibits both Abeta40 and Abeta42 fibril formation but does not affect Abeta40 or Abeta42-induced cytotoxicity in PC12 cells.

1 reference

12 December 2020

Synthesis and characterization of a peptide identified as a functional element in alphaA-crystallin

1 reference

12 December 2020

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

1 reference

12 December 2020

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy.

1 reference

12 December 2020

Parkinson's disease--a multifactorial neurodegenerative disorder.

1 reference

12 December 2020

Phe71 is essential for chaperone-like function in alpha A-crystallin

1 reference

12 December 2020

Identification of 1,1'-bi(4-anilino)naphthalene-5,5'-disulfonic acid binding sequences in alpha-crystallin.

1 reference

12 December 2020

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

12 December 2020

Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides

1 reference

12 December 2020

Modified-peptide inhibitors of amyloid beta-peptide polymerization.

1 reference

12 December 2020

Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease

1 reference

12 December 2020

Controlling amyloid beta-peptide fibril formation with protease-stable ligands

1 reference

12 December 2020

Inhibition of beta-amyloid production by activation of protein kinase C.

1 reference

12 December 2020

Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention

1 reference

12 December 2020

Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation

1 reference

12 December 2020

Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity.

1 reference

12 December 2020

Small heat shock proteins inhibit in vitro A beta(1-42) amyloidogenesis

1 reference

12 December 2020

Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation

1 reference

12 December 2020

A molecular model of Alzheimer amyloid beta-peptide fibril formation

1 reference

12 December 2020

Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein

1 reference

12 December 2020

Cataract, Alzheimer's disease, and other conformational diseases.

1 reference

12 December 2020

Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger.

1 reference

12 December 2020

Two-hybrid system as a model to study the interaction of beta-amyloid peptide monomers

1 reference

12 December 2020

10.1023/B:MCBI.0000049373.15558.B8

Identifiers

DOI

1 reference

PubMed ID

15663196

Dimensions Publication ID

11 December 2017

0 references

1 reference

PubMed ID

15663196